<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, the expansion of the botanical drug market has attracted significant interest from pharmaceutical companies, which have intensified their development of pre-clinical and pharmacological studies on such drugs forecasting a 6.1% CAGR growth of approximately 31.6 billion dollars for this field in the period between 2017 and 2022 (
 <xref rid="B121" ref-type="bibr">Market Watch, 2017</xref>). Hence, a steady increase in botanical drugs reaching the market should be expected in the years to come.
</p>
